These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. Chiti F; De Lorenzi E; Grossi S; Mangione P; Giorgetti S; Caccialanza G; Dobson CM; Merlini G; Ramponi G; Bellotti V J Biol Chem; 2001 Dec; 276(50):46714-21. PubMed ID: 11590172 [TBL] [Abstract][Full Text] [Related]
23. Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F. Sirangelo I; Malmo C; Iannuzzi C; Mezzogiorno A; Bianco MR; Papa M; Irace G J Biol Chem; 2004 Mar; 279(13):13183-9. PubMed ID: 14701846 [TBL] [Abstract][Full Text] [Related]
24. Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studies. Kim YS; Randolph TW; Stevens FJ; Carpenter JF J Biol Chem; 2002 Jul; 277(30):27240-6. PubMed ID: 12023282 [TBL] [Abstract][Full Text] [Related]
25. The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II. Ryan TM; Mok YF; Howlett GJ; Griffin MD Adv Exp Med Biol; 2015; 855():157-74. PubMed ID: 26149930 [TBL] [Abstract][Full Text] [Related]
26. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation. Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947 [TBL] [Abstract][Full Text] [Related]
27. Behavior of apolipoprotein C-II in an aqueous solution. Tajima S; Yokoyama S; Kawai Y; Yamamoto A J Biochem; 1982 Apr; 91(4):1273-9. PubMed ID: 7096287 [TBL] [Abstract][Full Text] [Related]
28. Solution Conditions Affect the Ability of the K30D Mutation To Prevent Amyloid Fibril Formation by Apolipoprotein C-II: Insights from Experiments and Theoretical Simulations. Mao Y; Todorova N; Zlatic CO; Gooley PR; Griffin MD; Howlett GJ; Yarovsky I Biochemistry; 2016 Jul; 55(27):3815-24. PubMed ID: 27311794 [TBL] [Abstract][Full Text] [Related]
29. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062 [TBL] [Abstract][Full Text] [Related]